Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Experience
  • Insights
  • Recognition

About Moritz

Moritz Ammelburg, Ph.D., is a principal in the Munich office of Fish & Richardson P.C. ​Moritz is an imaginative life scientist holding a doctorate in biochemistry. His practice focuses on patent prosecution in the biotechnology and pharma areas based on his deep understanding of the architecture and function of small compounds as well as macromolecules. Having a special interest in the dynamic law governing supplementary protection certificates (SPCs), he coordinates the prosecution of several families of SPC applications across Europe. Additionally, Moritz passionately fights for his clients in opposition proceedings before the European Patent Office (EPO).

Publications

  • Coordinating Patent Prosecution in the U.S. and Europe,” Managing IP (June 8, 2022)
  • Fuchs ACD, Ammelburg M, Martin J, Schmitz RA, Hartmann MD, Lupas AN.  Archaeal Connectase is a specific and efficient protein ligase related to proteasome β subunits. Proc Natl Acad Sci USA. Mar 16;118(11) (2021)
  • WO 2021/099484 A1.  Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.  Inventors: Fuchs A, Ammelburg M, Hartmann M.  Archaeal Peptide Recombinase – A Novel Peptide Ligating Enzyme
  • Forouzan D, Ammelburg M, Hobel CF, Ströh LJ, Sessler N, Martin J, Lupas AN. The archaeal proteasome is regulated by a network of AAA ATPases. J Biol Chem. Nov 9;287(46):39254-62 (2012)
  • Vogelmann J, Ammelburg M, Finger C, Guezguez J, Linke D, Flötenmeyer M, Stierhof YD, Wohlleben W, Muth G. Conjugal plasmid transfer in Streptomyces resembles bacterial chromosome segregation by FtsK/SpoIIIE. EMBO J. Jun 1;30(11):2246-54 (2011)
  • Ammelburg M, Hartmann MD, Djuranovic S, Alva V, Koretke KK, Martin J, Sauer G, Truffault V, Zeth K, Lupas AN, Coles M. A CTP-dependent archaeal riboflavin kinase forms a bridge in the evolution of cradle-loop barrels. Structure. Dec;15(12):1577-90 (2007)
  • Alva V, Ammelburg M, Söding J, Lupas AN. On the origin of the histone fold. BMC Struct Biol. Mar 28;7:17 (2007)
  • Ammelburg M, Frickey T, Lupas AN. Classification of AAA+ proteins. J Struct Biol. Oct;156(1):2-11 (2006)

Dissertation

  • Ammelburg M. AAA proteins and the origins of proteasomal protein degradation. University of Tuebingen (June 2012)

Speaking Engagements 

 

Selected Cases

Merck Sharp & Dohme Corp. and Neuefeind, Regina v. Mayo Foundation for Medical Education and Research – Represented Mayo Foundation in EPO opposition-appeal proceedings and defended European patent EP1234031. Patent was maintained including claim covering EMA approved therapeutic antibodies.

Pfizer Inc. and  Merck Patent GmbH v. Mayo Foundation for Medical Education and Research – Represented Mayo Foundation in EPO opposition proceedings and defended European patent EP3052131. Patent was maintained as granted.

Ammelburg, Moritz v. Bruschettini S.r.l. – Represented Opponent in EPO opposition proceedings and challenged European patent EP3016654. Patent was revoked in its entirety in first instance.

James Poole Limited v. Massachusetts Eye & Ear Infirmary – Represented Massachusetts Eye & Ear Infirmary in EPO opposition proceedings and defended European patent EP2381936. Patent was maintained and protection of the clinical embodiments was secured.

Ammelburg, Moritz v. Roche Diagnostics GmbH and F. Hoffmann-La Roche AG – Represented Opponent in EPO opposition proceedings and challenged European patent EP3213085. Patent was maintained in significantly limited form.

  • Ph.D. scholarship, Max Planck Society (2007-2009)
  • Member, German National Academic Foundation (2001-2006)
  • Scholarship, German Chemical Industry Fund (2000-2002)
Focus Areas
Education

Ph.D. magna cum laude, Biochemistry, University of Tuebingen (2011)


M.S., Biochemistry, Technical University of Munich (2006)


B.S., Biochemistry, Technical University of Munich (2003)

Admissions
  • Deutsches Patent- und Markenamt (German Patent and Trade Mark Office)
  • European Patent Office
Languages
  • English
  • German

What's trending with Moritz

Filter by
News
October 11, 2022
Unitary Patent and UPC Start Date Target Is Now 1 April 2023
Legal Alerts
News
News
June 14, 2022
Principals Moritz Ammelburg and Peter Fasse Author Managing IP Article "Coordinating Patent Prosecution in the U.S. and Europe"
Articles
Blog
April 28, 2022
WIPO Standard ST.26 is coming into force before the European Patent Office on July 1, 2022
Author: Moritz Ammelburg, Ph.D.
Event
May 17th, 2022 | 9:00 am PDT
Berkeley Center for Law & Technology (BCLT) Presentation | EPO Patent Prosecution Year in Review (for U.S. practitioners)
Speaking Engagement
Sponsorship
Event
May 12th, 2022 | 1:30 pm EDT
Webinar | Best Practices in European and U.S. Patent Law
Webinar
Event
April 26th, 2022 | 12:00 pm EDT
New York Intellectual Property Law Association (NYIPLA) Webinar | What You Need to Know About the EU Unitary Patent and Unified Patent Court
Speaking Engagement
Event
July 29th, 2021 | 1:00 pm EDT
Strafford Webinar | Managing Priority Between U.S. and European Patents: Minimizing Ownership, Same Invention, Scope, and Other Risks
Speaking Engagement
Event
March 10th, 2021 | 1:30 pm EST
Webinar | Coordinating Patent Prosecution in the U.S. and Europe
Webinar
News
January 5, 2021
Fish & Richardson Elevates Its Most Diverse Principal Class Ever
Press Release
News
Event
April 24th, 2017
Consero 2017 IP Forum for Life Sciences
Sponsorship
load more topics
TOP